Buccal absorption of ergotamine
Open Access
- 1 October 1974
- journal article
- research article
- Published by BMJ in Journal of Neurology, Neurosurgery & Psychiatry
- Vol. 37 (10) , 1116-1120
- https://doi.org/10.1136/jnnp.37.10.1116
Abstract
The rate of disappearance of ergotamine from the mouth after buccal administration has been studied in seven subjects. Allowance has been made for non-absorptive losses of the drug due to experimental technique. The absorption of ergotamine across the buccal mucosa appears to be a passive process, pH-dependent but independent of ergotamine concentration or the simultaneous presence of caffeine. Because of the low solubility of ergotamine at the pH of saliva, it is unlikely that therapeutically useful amounts of the drug would have absorbed across the buccal mucosa even after the drug had been in the mouth for five minutes.Keywords
This publication has 16 references indexed in Scilit:
- Fluorimetric assay of ergotamineAnalytica Chimica Acta, 1974
- Physical Chemistry of Ergot Alkaloids and Derivatives I: Ionization Constants of Several Medicinally Active BasesJournal of Pharmaceutical Sciences, 1970
- Complexes of Ergot Alkaloids and Derivatives I: The Interaction of Caffeine with Ergotamine Tartrate in Aqueous SolutionJournal of Pharmaceutical Sciences, 1969
- The influence of alkyl substitution in acids on their performance in the buccal absorption testJournal of Pharmacy and Pharmacology, 1968
- Clinical Trial of Inhaled Ergotamine Tartrate in MigraineBMJ, 1964
- Rectal Use of Ergotamine Tartrate and Caffeine Alkaloid for the Relief of MigraineNew England Journal of Medicine, 1954
- RECENT ADVANCES IN TREATMENT OF MIGRAINEJAMA, 1951
- Clinical Observations on the Rectal and Oral Use of Various Ergot Derivatives in HeadacheNew England Journal of Medicine, 1950
- Observations on the Symptomatic Treatment of Chronic Vascular Headache with Cafergone (Ergotamine Tartrate and Caffeine)New England Journal of Medicine, 1949
- ERGOTAMINE TARTRATE IN MIGRAINEThe Lancet, 1937